Interleukin-6, interleukin-8, and a rapid and sensitive assay for calcitonin precursors for the determination of bacterial sepsis in febrile neutropenic children
- 1 March 2005
- journal article
- clinical trial
- Published by Ovid Technologies (Wolters Kluwer Health) in Pediatric Critical Care Medicine
- Vol. 6 (2), 129-135
- https://doi.org/10.1097/01.pcc.0000149317.15274.48
Abstract
Children with cancer often develop febrile illnesses after cytotoxic chemotherapy. Determining which children have serious bacterial infections in this vulnerable period would be valuable. We evaluated the ability of a rapid and sensitive assay for the concentration of calcitonin precursors (CTpr) as a sensitive diagnostic marker for bacterial sepsis in febrile, neutropenic children and determined the utility of measuring cytokines to improve the predictive value of this approach. Prospective cohort study. Academic children’s hospital. Fifty-six children (aged 5 months to 17 yrs) with a known malignancy who presented with fever and neutropenia. Serial blood samples were obtained (admission, 24 hrs, and 48 hrs), and concentrations of CTpr, interleukin-6, and interleukin-8 were determined. Demographic and laboratory data from the patients were collected from the medical record. Sixteen (29%) of the children met the criteria for bacterial sepsis. Plasma levels of CTpr and interleukin-8, but not interleukin-6, were increased at all time points in children with sepsis compared with those without sepsis. CTpr at 24 and 48 hrs after admission were reliable markers for sepsis (area under the curve = 0.92 and 0.908, respectively). Logistic regression using CTpr at 24 hrs in addition to interleukin-8 at 48 hrs produced the best-fit models associated with sepsis. Using cutoff values of CTpr >500 pg/mL and interleukin-8 >20 pg/mL produced a screening test for sepsis with 94% sensitivity and 90% specificity. Our data show the utility of a rapid and sensitive assay for CTpr combined with interleukin-8 as a highly sensitive and specific diagnostic marker of bacterial sepsis in febrile, neutropenic children. The use of these markers as a clinical tool may allow for better prognostication for clinicians and may eventually lead to more targeted therapies for this heterogeneous population.Keywords
This publication has 41 references indexed in Scilit:
- Circulating Inflammatory Mediators in Patients with Fever: Predicting Bloodstream InfectionClinical and Diagnostic Laboratory Immunology, 2001
- Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor IIBritish Journal of Haematology, 2000
- Improved outcomes of children with malignancy admitted to a pediatric intensive care unitCritical Care Medicine, 2000
- Usefulness of procalcitonin for diagnosis of infection in cardiac surgical patientsCritical Care Medicine, 2000
- Outcome Prediction by Traditional and New Markers of Inflammation in Patients with Sepsiscclm, 1999
- Procalcitonin in patients with and without immunosuppression and sepsisInfection, 1996
- Procalcitonin as a marker for the early diagnosis of neonatal infectionThe Journal of Pediatrics, 1996
- American College of Chest Physicians/Society of Critical Care Medicine Consensus ConferenceCritical Care Medicine, 1992
- The child with cancer and infection. I. Empiric therapy for fever and neutropenia, and preventive strategiesThe Journal of Pediatrics, 1991
- Basic principles of ROC analysisSeminars in Nuclear Medicine, 1978